- Home
- LXEH vs ANVS Comparison
LXEH vs ANVS Comparison
Compare LXEH & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LXEH | ANVS |
|---|---|---|
| Founded | 2001 | 2008 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5M | 111.3M |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | LXEH | ANVS |
|---|---|---|
| Price | $0.22 | $2.57 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $13.50 |
| AVG Volume (30 Days) | ★ 709.8K | 314.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 62.92 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.18 | $1.11 |
| 52 Week High | $50.08 | $5.50 |
Technical Indicators
Market Signals| Indicator | LXEH | ANVS |
|---|---|---|
| Relative Strength Index (RSI) | 48.25 | 46.37 |
| Support Level | $0.18 | $2.27 |
| Resistance Level | $0.28 | $2.63 |
| Average True Range (ATR) | 0.03 | 0.20 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 19.20 | 33.85 |
Price Performance
Historical ComparisonAbout LXEH Lixiang Education Holding Co. Ltd.
Lixiang Education Holding Co Ltd is a private primary and secondary education service provider in Lishui City, Zhejiang Province. Its private education services primarily include primary and middle school education from grade 1 to grade 9. The company also offers high school education services at its High School Divisions.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.